Reata Pharmaceuticals Inc sell Wolf_of_WS
Summary
This prediction ended on 03.04.23 with a price of €87.50. The prediction closed with a disappointing performance of 11.47%. Wolf_of_WS has 50% into this predictionReata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on identifying, developing, and commercializing novel therapeutics for patients with severe and life-threatening diseases. The company's primary business areas include drug discovery and development in fields such as cardiovascular, fibrotic, mitochondrial, and neurodegenerative diseases. With a strong emphasis on research and innovation, Reata Pharmaceuticals seeks to deliver cutting-edge treatments that address unmet medical needs, improve patient outcomes, and significantly impact the lives of those suffering from rare and debilitating conditions. As a publicly traded company, Reata Pharmaceuticals is listed on the NASDAQ stock exchange under the ticker symbol "RETA."
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Reata Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | 1.804% | -0.748% | 13.168% |
iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
iShares S&P 500 | 0.664% | -1.941% | 28.141% |
Comments by Wolf_of_WS for this prediction
In the thread Reata Pharmaceuticals Inc diskutieren
In the thread Trading Reata Pharmaceuticals Inc